Group One Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-135,300
| Closed | -$2.43M | – | 6851 |
|
|
2020
Q2 | $2.43M | Buy |
135,300
+93,300
| +222% | +$1.3M | 0.01% | 1330 |
|
|
2020
Q1 | $299K | Sell |
42,000
-3,800
| -8% | -$47.4K | ﹤0.01% | 2430 |
|
|
2019
Q4 | $1.09M | Sell |
45,800
-3,700
| -7% | -$102K | 0.01% | 1799 |
|
|
2019
Q3 | $1.33M | Sell |
49,500
-7,600
| -13% | -$213K | 0.01% | 1514 |
|
|
2019
Q2 | $1.55M | Buy |
57,100
+29,700
| +108% | +$931K | 0.01% | 1283 |
|
|
2019
Q1 | $951K | Sell |
27,400
-93,500
| -77% | -$2.7M | 0.01% | 1445 |
|
|
2018
Q4 | $2.36M | Buy |
120,900
+72,900
| +152% | +$1.5M | 0.02% | 926 |
|
|
2018
Q3 | $1.28M | Sell |
48,000
-15,500
| -24% | -$506K | 0.01% | 1501 |
|
|
2018
Q2 | $2.4M | Sell |
63,500
-38,900
| -38% | -$1.49M | 0.02% | 1007 |
|
|
2018
Q1 | $3.34M | Sell |
102,400
-23,900
| -19% | -$1.05M | 0.03% | 676 |
|
|
2017
Q4 | $6.15M | Buy |
126,300
+29,000
| +30% | +$1.47M | 0.04% | 535 |
|
|
2017
Q3 | $5.26M | Sell |
97,300
-53,200
| -35% | -$3.12M | 0.05% | 493 |
|
|
2017
Q2 | $8.45M | Buy |
150,500
+75,000
| +99% | +$3M | 0.09% | 260 |
|
|
2017
Q1 | $2.96M | Buy |
75,500
+1,200
| +2% | +$38.2K | 0.03% | 634 |
|
|
2016
Q4 | $1.67M | Buy |
74,300
+52,300
| +238% | +$1.02M | 0.02% | 1021 |
|
|
2016
Q3 | $500K | Buy |
22,000
+15,000
| +214% | +$352K | 0.01% | 1821 |
|
|
2016
Q2 | $165K | Sell |
7,000
-27,200
| -80% | -$672K | ﹤0.01% | 2530 |
|
|
2016
Q1 | $698K | Buy |
34,200
+25,800
| +307% | +$819K | 0.01% | 1450 |
|
|
2015
Q4 | $432K | Buy |
8,400
+5,000
| +147% | +$242K | 0.01% | 1933 |
|
|
2015
Q3 | $145K | Sell |
3,400
-19,300
| -85% | -$931K | ﹤0.01% | 2753 |
|
|
2015
Q2 | $1.03M | Buy |
22,700
+11,600
| +105% | +$467K | 0.01% | 1177 |
|
|
2015
Q1 | $421K | Buy |
11,100
+8,400
| +311% | +$289K | 0.01% | 1748 |
|
|
2014
Q4 | $76K | Buy |
2,700
+1,400
| +108% | +$38.9K | ﹤0.01% | 3073 |
|
|
2014
Q3 | $33K | Buy |
1,300
+1,100
| +550% | +$29K | ﹤0.01% | 3820 |
|
|
2014
Q2 | $6K | Buy |
+200
| New | +$4.84K | ﹤0.01% | 4718 |
|
Group One Trading's PTLA Position: Q3 2020 in Review
Group One Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 56,437 shares — an estimated $1.01M sold.
Group One Trading first reported a position in PTLA in Q2 2014 and held it in 22 quarters. The position peaked at $5.66M in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Group One Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Group One Trading sold 56,437 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.01M.
- Group One Trading first reported a position in Portola Pharmaceuticals, Inc. in Q2 2014 and held it in 22 quarters.
- Group One Trading's Portola Pharmaceuticals, Inc. position peaked at $5.66M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Group One Trading's 13F filing for Q3 2020, filed 12 Nov 2020.